Complementary and Alternative Medicine Use in Chronic Liver Disease Patients

Leah M. Ferrucci, Beth P. Bell, Kathy B. Dhotre, M. Michele Manos, Norah A. Terrault, Atif Zaman, Rosemary C. Murphy, Grace R. VanNess, Ann R. Thomas, Stephanie R. Bialek, Mayur M. Desai, Andre N. Sofair

Research output: Contribution to journalArticlepeer-review

41 Scopus citations


To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns.

Original languageEnglish (US)
Pages (from-to)e40-e45
JournalJournal of clinical gastroenterology
Issue number2
StatePublished - Feb 2010


  • Chronic liver disease
  • Complementary and alternative medicine
  • Epidemiology

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Complementary and Alternative Medicine Use in Chronic Liver Disease Patients'. Together they form a unique fingerprint.

Cite this